Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Creation Ventures (CCV) is a prominent venture capital firm based in Beijing, China, founded by the former core investment team of KPCB China. The firm specializes in early and growth-stage investments across the technology and healthcare sectors, with a particular focus on artificial intelligence, digital health, and innovative biotechnology. CCV leverages its deep industry expertise and global network to support visionary entrepreneurs in scaling transformative healthcare technologies. Their life sciences portfolio includes companies focused on GPCR-targeted therapies, AI-driven drug discovery, and advanced medical devices. The firm manages both USD and RMB funds, providing strategic capital to startups aiming for both domestic and international growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Creation Ventures.